6678 Stock Overview
Engages in the research and development, manufacture, sale, import, and export of in-vitro diagnostic analyzers in Japan.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
Techno Medica Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥1,785.00 |
| 52 Week High | JP¥2,625.00 |
| 52 Week Low | JP¥1,687.00 |
| Beta | 0.13 |
| 11 Month Change | -0.22% |
| 3 Month Change | 0.85% |
| 1 Year Change | -4.95% |
| 33 Year Change | 11.49% |
| 5 Year Change | -17.78% |
| Change since IPO | 61.78% |
Recent News & Updates
Recent updates
Shareholder Returns
| 6678 | JP Medical Equipment | JP Market | |
|---|---|---|---|
| 7D | -0.8% | 2.9% | 2.7% |
| 1Y | -5.0% | 8.0% | 18.6% |
Return vs Industry: 6678 underperformed the JP Medical Equipment industry which returned 8% over the past year.
Return vs Market: 6678 underperformed the JP Market which returned 18.6% over the past year.
Price Volatility
| 6678 volatility | |
|---|---|
| 6678 Average Weekly Movement | 2.9% |
| Medical Equipment Industry Average Movement | 3.7% |
| Market Average Movement | 3.9% |
| 10% most volatile stocks in JP Market | 7.3% |
| 10% least volatile stocks in JP Market | 2.1% |
Stable Share Price: 6678 has not had significant price volatility in the past 3 months.
Volatility Over Time: 6678's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1987 | 225 | Masatomo Saneyoshi | www.technomedica.co.jp |
Techno Medica Co., Ltd. engages in the research and development, manufacture, sale, import, and export of in-vitro diagnostic analyzers in Japan. The company offers automated tube selecting and labeling systems, RFID specimen management, inspection reception systems, reception and collation systems, automated urine aliquot and labeling systems, pre-analytical instruments, and blood and urine collection support, as well as blood gas, electrolytes, erythrocyte sedimentation rates, and ion selective electrode-certificated serums. It also provides consumables and after sales services.
Techno Medica Co., Ltd. Fundamentals Summary
| 6678 fundamental statistics | |
|---|---|
| Market cap | JP¥12.35b |
| Earnings (TTM) | JP¥1.35b |
| Revenue (TTM) | JP¥10.28b |
9.2x
P/E Ratio1.2x
P/S RatioIs 6678 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 6678 income statement (TTM) | |
|---|---|
| Revenue | JP¥10.28b |
| Cost of Revenue | JP¥5.13b |
| Gross Profit | JP¥5.15b |
| Other Expenses | JP¥3.80b |
| Earnings | JP¥1.35b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Aug 07, 2024
| Earnings per share (EPS) | 194.87 |
| Gross Margin | 50.10% |
| Net Profit Margin | 13.11% |
| Debt/Equity Ratio | 0% |
How did 6678 perform over the long term?
See historical performance and comparison